Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus

E-ISSN： 1463-1326|17|4|426-429

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.17, Iss.4, 2015-04, pp. : 426-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of Canagliflozin in Patients with Type 2 Diabetes

Current Drug Safety, Vol. 9, Iss. 2, 2014-07 ,pp. : 127-132

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of the Effect of Pentoxifylline and Captopril on Proteinuria in Patients with Type 2 Diabetes mellitus

Nephron Clin Pract, Vol. 99, Iss. 3, 2005-01 ,pp. : c73-c77

Karger

Access to resources Recommend Favorite

Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group comparative study

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 453-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with Type 2 diabetes mellitus

By Mojiminiyi O. A. Abdella N. George S.

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 60, Iss. 6, 2000-11 ,pp. : 483-489

Informa Healthcare

Access to resources Recommend Favorite

Response to Serum cytokeratin‐18 fragment levels predict development of type 2 diabetes mellitus in adult patients with NAFLD

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2622-2622

John Wiley & Sons Inc

Access to resources Recommend Favorite